Candriam SCA’s Hims & Hers Health HIMS Stock Holding History

Candriam SCA’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-306,273	Closed	-$17.4M	–	696
2025 Q3	$17.4M	Buy	306,273 +217,493	+245%	+$11.1M	0.09%	197
2025 Q2	$4.43M	Buy	+88,780	New	+$4.01M	0.03%	376

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Candriam SCA's HIMS Position: Q4 2025 in Review

Candriam SCA sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 306,273 shares — an estimated $17.4M sold.

Candriam SCA first reported a position in HIMS in Q2 2025 and held it in 2 quarters. The position peaked at $17.4M in Q3 2025. 486 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

Candriam SCA reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
Candriam SCA sold 306,273 Hims & Hers Health shares in Q4 2025, an estimated $17.4M.
Candriam SCA first reported a position in Hims & Hers Health in Q2 2025 and held it in 2 quarters.
Candriam SCA's Hims & Hers Health position peaked at $17.4M in Q3 2025.
486 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.